149 related articles for article (PubMed ID: 17571254)
1. Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of Neoimmun.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Faerber L; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):393-9. PubMed ID: 17571254
[TBL] [Abstract][Full Text] [Related]
2. Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral.
Kees F; Mair G; Dittmar M; Bucher M
Transplant Proc; 2004 Dec; 36(10):3234-8. PubMed ID: 15686736
[TBL] [Abstract][Full Text] [Related]
3. Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation.
Yang SG; Kim DD; Chung SJ; Shim CK
Int J Clin Pharmacol Ther; 2006 May; 44(5):233-9. PubMed ID: 16724578
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L
Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713
[TBL] [Abstract][Full Text] [Related]
5. [Bioequivalence research of cyclosporin soft capsules].
Wu Y; Mao M; Wang L; Jiang X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):311-4, 331. PubMed ID: 22616181
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine bioequivalence study: quantification using fluorescence polarization immunoassay (FPIA) and radioimmunoassay (RIA).
Mendes GD; de Oliveira CH; Sucupira M; Donato JL; Moreno RA; De Nucci G
Int J Clin Pharmacol Ther; 2004 Feb; 42(2):125-32. PubMed ID: 15180174
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis.
Fu LW; Yang LY; Chen WP; Lin CY
Br J Clin Pharmacol; 1997 Aug; 44(2):125-7. PubMed ID: 9278195
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two cyclosporine formulations in healthy volunteers: bioequivalence of the new Sang-35 formulation and Neoral.
Schroeder TJ; Cho MJ; Pollack GM; Floc'h R; Moran HB; Levy R; Moore LW; Pouletty P
J Clin Pharmacol; 1998 Sep; 38(9):807-14. PubMed ID: 9753208
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of Neoplanta capsule to Sandimmune Neoral, microemulsion formulations of cyclosporin A in human subjects.
Lee YJ; Chung SJ; Shim CK
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):210-5. PubMed ID: 9587047
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two cyclosporine formulations in healthy Middle Eastern volunteers: bioequivalence of the new Sigmasporin Microoral and Sandimmun Neoral.
Najib NM; Idkaidek N; Adel A; Mohammed B; Al-Masri S; Admour I; Alam SM; Dham R; Qumaruzaman
Eur J Pharm Biopharm; 2003 Jan; 55(1):67-70. PubMed ID: 12551705
[TBL] [Abstract][Full Text] [Related]
11. A bioavailability study of cyclosporine: comparison of Neoral versus Cysporin in stable heart transplant recipients.
Leet A; Richardson M; Senior JA; Funston R; Skiba M; Bailey M; Krum H
J Heart Lung Transplant; 2009 Sep; 28(9):894-8. PubMed ID: 19716041
[TBL] [Abstract][Full Text] [Related]
12. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
Ritschel WA
Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine bioavailability of Neoral and Sandimmune in white and black de novo renal transplant recipients. Neoral Study Group.
Pollak R; Wong RL; Chang CT
Ther Drug Monit; 1999 Dec; 21(6):661-3. PubMed ID: 10604829
[TBL] [Abstract][Full Text] [Related]
14. Modifications in cyclosporine (CsA) microemulsion blood concentrations by olestra.
Terrill CJ; Lill J; Somerville KT; Sherbotie JR
J Ren Nutr; 2003 Jan; 13(1):26-30. PubMed ID: 12563620
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R
Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203
[TBL] [Abstract][Full Text] [Related]
16. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs.
Fischer JR; Harkin KR; Freeman LC
Vet Ther; 2002; 3(4):465-73. PubMed ID: 12584684
[TBL] [Abstract][Full Text] [Related]
17. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation.
Mueller EA; Kovarik JM; van Bree JB; Tetzloff W; Grevel J; Kutz K
Pharm Res; 1994 Feb; 11(2):301-4. PubMed ID: 8165192
[TBL] [Abstract][Full Text] [Related]
18. Pomegranate Juice does not Affect the Bioavailability of Cyclosporine in Healthy Thai Volunteers.
Anlamlert W; Sermsappasuk P
Curr Clin Pharmacol; 2020; 15(2):145-151. PubMed ID: 31924158
[TBL] [Abstract][Full Text] [Related]
19. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter?
Ku YM; Min DI; Flanigan M
J Clin Pharmacol; 1998 Oct; 38(10):959-65. PubMed ID: 9807978
[TBL] [Abstract][Full Text] [Related]
20. Testing switchability of a new microemulsion formulation of cyclosporine.
Talaulikar GS; Srishyla MV; Job V; Selvakumar R; Thomas PP
Transplant Proc; 2003 Dec; 35(8):2899-901. PubMed ID: 14697932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
